FTRE - Fortrea Holdings Inc
IEX Last Trade
23.05
-0.100 -0.434%
Share volume: 1,095,783
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$23.15
-0.10
-0.43%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2023-07-03 | 2023-08-14 | 2023-11-13 | 2024-03-13 | 2024-05-24 | |
| Total revenue | 764.200 M | 793.000 M | 776.400 M | 775.400 M | 662.100 M | |
| Cost of revenue | 636.200 M | 649.400 M | 647.300 M | 655.700 M | 554.200 M | |
| Gross profit | 128.000 M | 143.600 M | 129.100 M | 119.700 M | 107.900 M | |
| 12.19% | -10.10% | -7.28% | -9.86% | |||
| Operating expenses | 78.000 M | 80.800 M | 78.900 M | 98.900 M | 120.100 M | |
| Selling general and admin | 78.000 M | 80.800 M | 78.900 M | 98.900 M | 120.100 M | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 737.000 M | 755.300 M | 750.800 M | 778.500 M | 696.200 M | |
| 2.48% | -0.60% | 3.69% | -10.57% | |||
| Operating income | 27.200 M | 37.700 M | 25.600 M | -3.100 M | -34.100 M | |
| Ebit | 27.200 M | 37.700 M | 25.600 M | -3.100 M | -34.100 M | |
| Pretax income | 21.100 M | 38.900 M | -17.900 M | -41.000 M | -75.700 M | |
| 84.36% | -146.02% | 129.05% | 84.63% | |||
| Income tax | 3.700 M | 10.600 M | -4.800 M | -5.000 M | 4.100 M | |
| Net income basic | 17.400 M | 28.300 M | -13.100 M | -36.000 M | -101.000 M | |
| 62.64% | -146.29% | -174.81% | -180.56% | |||
| Net income | 17.400 M | 28.300 M | -13.100 M | -36.000 M | -101.000 M | |
| 62.64% | -146.29% | -174.81% | -180.56% |